Human HER-2 gene amplification detection probe, HER2/CEP17 CE-IVD
Catalog No : FP-001
513.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Human HER-2 gene amplification detection probe, HER2/CEP17 CE-IVD | ||
|---|---|---|---|
| Catalog No | FP-001 | ||
| Supplier’s Catalog No | FP-001 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | HER2 | ||
| Reactivity | HER2/CEP17, For the diagnosis and subtyping of breast cancer. | ||
| Cross reactivity | None | ||
| Applications | FISH (Fluorescence In Situ Hybridization) for diagnosis of human Lymphomas | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Professional In Vitro diagnostics | ||
| Description | HER2 gene amplification can be found in many cancers such as breast cancer, hernia, small cell lung cancer, ovarian cancer, prostate cancer, colorectal cancer, salivary glands, etc., and is more common in breast cancer. Breast cancer is one of the most common malignant tumors in women. The incidence rate accounts for 7-10% of all malignant tumors in the whole body. About 20-35% breast cancer patients have HER2 gene amplification high protein expression. Breast cancer patients are recommended routine detection of HER2 gene status. | ||
Product Details
© 2020 Imugex All Rights Reserved